The Transcription Factor MEF/Elf4 Is Dually Modulated by p53-MDM2 Axis and MEF-MDM2 Autoregulatory Mechanism

被引:17
|
作者
Suico, Mary Ann [1 ]
Fukuda, Ryosuke [1 ]
Miyakita, Rui [1 ]
Koyama, Kosuke [1 ]
Taura, Manabu [1 ]
Shuto, Tsuyoshi [1 ]
Kai, Hirofumi [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan
关键词
MYELOID ELF-1-LIKE FACTOR; REGULATES LYSOZYME TRANSCRIPTION; PROMYELOCYTIC LEUKEMIA PROTEIN; TUMOR-SUPPRESSOR P53; EPITHELIAL-CELLS; FACTOR MEF; HUMAN BETA-DEFENSIN-2; HEMATOPOIETIC-CELLS; CARCINOMA CELLS; ENDOGENOUS P53;
D O I
10.1074/jbc.M114.580209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myeloid Elf-1-like factor (MEF) or Elf4 is an ETS transcription factor that activates innate immunity-associated genes such as lysozyme (LYZ), human beta-defensin 2 (H beta D2), and interleukin-8 (IL-8) in epithelial cells and is also known to influence cell cycle progression. MEF is transcriptionally activated by E2F1, but the E2F1-mediated transcriptional activation is inhibited by p53 through E2F1-p53 protein interaction. Although the transcriptional activation of MEF has been investigated in depth, its post-translational regulation is not well explored. By overexpressing MEF cDNA in human cell lines, here we show that MEF protein expression is suppressed by p53. By screening a number of E3 ligases regulated by p53, we found that MDM2 is involved in the effect of p53 on MEF. MDM2 is transcriptionally activated by p53 and interacts with MEF protein to enhance MEF degradation. MDM2 reduces MEF protein expression, as well as stability and function of MEF as transcriptional activator. Furthermore, MDM2 was able to down-regulate MEF in the absence of p53, indicating a p53-independent effect on MEF. Notably, MEF transcriptionally activates MDM2, which was previously demonstrated to be the mechanism by which MEF suppresses the p53 protein. These results reveal that in addition to the potential of MEF to down-regulate p53 by transcriptionally activating E3 ligase MDM2, MEF participates with MDM2 in a novel autoregulatory feedback loop to regulate itself. Taken together with the findings on the effect of p53 on MEF, these data provide evidence that the p53-MDM2-MEF axis is a feedback mechanism that exquisitely controls the balance of these transcriptional regulators.
引用
收藏
页码:26143 / 26154
页数:12
相关论文
共 50 条
  • [41] Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 1
    Wang, Weisi
    Shangguan, Shihao
    Qiu, Ni
    Hu, Chunqi
    Zhang, Lei
    Hu, Yongzhou
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (11) : 2879 - 2885
  • [42] The MDM4/MDM2-p53-IGF1 axis controls axonal regeneration, sprouting and functional recovery after CNS injury (vol 138, pg 1843, 2015)
    Joshi, Yashashree
    Soria, Marilia Grando
    Quadrato, Giorgia
    Inak, Gizem
    Zhou, Luming
    Hervera, Arnau
    Rathore, Khizr I.
    Elnaggar, Mohamed
    Cucchiarini, Magali
    Marine, Jeanne Christophe
    Puttagunta, Radhika
    Di Giovanni, Simone
    BRAIN, 2016, 139 : E7 - E7
  • [43] Design, synthesis and CoMFA studies of N1-amino acid substituted 2,4,5-triphenyl imidazoline derivatives as p53-MDM2 binding inhibitors
    Hu, Chunqi
    Dou, Xiaoxue
    Wu, Yizhe
    Zhang, Lei
    Hua, Yongzhou
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (04) : 1417 - 1424
  • [44] CCT8 drives colorectal cancer progression via the RPL4-MDM2-p53 axis and immune modulation
    Yangyang Teng
    Hao Lin
    Zijian Lin
    Xichen Li
    Yejiao Ruan
    Binhui Pan
    Jinlin Ge
    Yuesheng Zhu
    Daopo Lin
    Qingji Ying
    Zhenzhai Cai
    Xuanping Xia
    BMC Medical Genomics, 18 (1)
  • [45] Mechanism of action and therapeutic potential of a new, promising non-peptide small-molecule inhibitor (MI-43) of the p53-MDM2 interaction.
    Shangary, S
    Ding, K
    Qiu, S
    Nikolovska-Coleska, Z
    Lu, YP
    McEachern, D
    Wang, SM
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9145S - 9146S
  • [46] Rescue of K562 cells from MDM2-modulated p53-dependent apoptosis by growth factor-induced differentiation
    Mahdi, T
    Alcalay, D
    Cognard, C
    Tanzer, J
    Kitzis, A
    BIOLOGY OF THE CELL, 1998, 90 (09) : 615 - 627
  • [47] UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation
    Wu, Hong
    Leng, Roger P.
    CELL CYCLE, 2011, 10 (12) : 1912 - 1915
  • [48] The p53 Pathway Is Frequently Deregulated in Pediatric Burkitt Lymphoma, but over Expression of MDM2 or HDM4 Is Not a Common Mechanism
    Leventaki, V.
    Rodic, V.
    Jahromi, M. S.
    Downie, J. M.
    Tripp, S. R.
    Bayerl, M. G.
    Perkins, S. L.
    Barnette, P.
    Schiffman, J. D.
    Miles, R. R.
    LABORATORY INVESTIGATION, 2011, 91 : 306A - 306A
  • [49] The p53 Pathway Is Frequently Deregulated in Pediatric Burkitt Lymphoma, but over Expression of MDM2 or HDM4 Is Not a Common Mechanism
    Leventaki, V.
    Rodic, V.
    Jahromi, M. S.
    Downie, J. M.
    Tripp, S. R.
    Bayerl, M. G.
    Perkins, S. L.
    Barnette, P.
    Schiffman, J. D.
    Miles, R. R.
    MODERN PATHOLOGY, 2011, 24 : 306A - 306A
  • [50] MDM2 activates NF-kB/p65 gene transcription through sp1-binding site in acute lymphoblastic leukemia cells: A novel, p53-independent mechanism by which MDM2 confers resistance to chemotherapy.
    Gu, LB
    Findley, HW
    Woods, WG
    Zhou, MX
    BLOOD, 2001, 98 (11) : 303A - 303A